SYS-CON MEDIA Authors: Lori MacVittie, Gilad Parann-Nissany, Unitiv Blog, Bob Gourley, Kevin Benedict

News Feed Item

Law Office of Brodsky & Smith, LLC Announces Investigation of Kayak Software Corporation

BALA CYNWYD, Pa., Nov. 10, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Kayak Software Corporation ("Kayak" or the "Company") (Nasdaq- KYAK-News) relating to the proposed acquisition by Priceline.com Inc. ("Priceline").

Under the terms of the transaction, Kayak shareholders may elect to receive either cash or stock with a value of $40.00 for each share on Kayak common stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Kayak for not acting in the Company's shareholders' best interests in connection with the sale process to Priceline. Specifically, the investigation seeks to determine if conflicts of interest played a role in the transaction as, following the merger, Kayak's current management team will continue to manage Kayak's operations.

If you own shares of Kayak stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [email protected] visiting http://brodsky-smith.com/502-kyak-kayak-software-corporation.html, by calling toll free 877-LEGAL-90.

SOURCE Brodsky & Smith, LLC

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.